We next sought to investigate CLL samples and found that CLL platelets activated Btk in response to IV.3-xl, bacteria, CRP-xl and TRAP-6 to a similar degree as healthy controls (compare Figures 5A, D). The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.